Alto Neuroscience, Inc. · NYSE:ANRO
Armistice Capital, LLC reported a 5.91% stake in Alto Neuroscience, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 15, 2025
Armistice Capital, LLC reported a 5.91% stake in Alto Neuroscience, Inc., 1,600,000 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).
- Stake
- 5.91%
- Shares
- 1,600,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 5.91% | 1,600,000 |
| Steven Boyd | 5.91% | 1,600,000 |
Source
Related
- Alto Neuroscience, Inc.
- Armistice Capital, LLC
- Alto Neuroscience, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Feb 18, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2025
- Form 4 · Smith Nicholas Conrad · Oct 5, 2026
- Form 4 · Smith Nicholas Conrad · Oct 1, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026